Femoropopliteal bypass: In situ or reversed vein grafts? Ten-year results of a randomized prospective study

Annals of Vascular Surgery

Volumn 11, Issue 5, 1997, Pages 510-519

  Watelet, Jacques ^a   Soury, Patrick ^a   Menard, Jean François ^a   Plissonnier, Didier ^a   Peillon, Christophe ^a   Lestrat, Jean Pierre ^a   Testart, Jacques ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMOROPOPLITEAL BYPASS; FOLLOW UP; GRAFT PATENCY; HUMAN; INTERMETHOD COMPARISON; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VEIN GRAFT;

EID: 0030799021     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100169900083     Document Type: Conference Paper

References (28)

1. Taylor LM, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: Five-year results of a modern series. J Vasc Surg 1990;11:193-206.
2. Leather RP, Shah DM, Chang BB, Kaufman JL. Resurrection of the in situ saphenous vein bypass, 1000 cases later. Ann Surg 1988;208:435-442.
3. Bergamini TM, Towne JB, Bandyk DF, et al. Experience with in situ saphenous vein bypasses during 1981 to 1989: Determinant factors of long-term patency. J Vasc Surg 1991; 13:137-149.
4. Batson RC, Sottiurai VS. Non-reversed and in situ vein grafts: Clinical and experimental observations. Ann Surg 1985;201:771-779.
5. Bush HL, Mc Cabe ME, Nabseth DC. Functional injury of vein graft endothelium: Role of hypothermia and distension. Arch Surg 1984;119:770-774.
6. Cambria RP, Megerman J, Abbott WM. Endothelial preservation in reversed and in situ autogenous vein grafts: A quantitative experimental study. Ann Surg 1985;202:50-55.
7. Sayers RD, Watt PAC, Muller S, et al. Endothelial cell injury secondary to surgical preparation of reversed and in situ saphenous vein bypass grafts. Eur J Vasc Surg 1992;6:354-361.
8. Harris PL, How TV, Jones DR. Prospectively randomized clinical trial to compare in situ and reversed saphenous vein grafts for femoropopliteal bypass. Br J Surg 1987;74:252-255.
9. Watelet J, Cheysson E, Poels D, et al. In situ versus reversed saphenous vein for femoropopliteal bypass: A prospective randomized study of 100 cases. Ann Vasc Surg 1986;1:441-452.
10. Wengerter KR, Veith FJ, Gupta SK, et al. Prospective randomized multicenter comparison of in situ and reversed vein infrapopliteal bypasses. J Vasc Surg 1991;13:189-199.
11. Rutherford RB, Flanigan DP, Gupta SK, et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg 1986;4:80-94.
12. DeWeese JA, Rob CG. Autogenous venous bypass grafts ten years later. Surgery 1977;82:755-784.
13. Towne JB. A prospective study to compare in situ bypasses with reversed vein for lower limb revascularization. J Vasc Surg 1992;15:893-895.
14. Mills JL, Harris EJ, Taylor LM, et al. The importance of routine surveillance of distal bypass grafts with duplex scanning: A study of 379 reversed vein grafts. J Vasc Surg 1990; 12:379-389.
15. Grigg MJ, Nicolaides AN, Wolfe JHN. Femorodistal vein bypass graft stenosis. Br J Surg 1988;75:737-740.
16. Moody AP, Edwards PR, Harris PL. The aetiology of vein graft strictures: A prospective marker study. Eur J Vasc Surg 1992;6:509-511.
17. Berkowitz HD, Fox AD, Deaton DH. Reversed vein graft stenosis: Early diagnosis and management. J Vasc Surg 1992; 15:130-142.
18. Mills JL, Fujitani RM, Taylor SM. The characteristics and anatomic distribution of lesions that cause reversed vein graft failure: A five-year prospective study. J Vasc Surg 1993; 17:195-206.
19. Donaldson MC, Mannick JA, Whittemore AD. Causes of primary graft failure after in situ saphenous vein bypass grafting. J Vasc Surg 1992;15:113-120.
20. Reifsnyder T, Towne JB, Seabrook GR, et al. Biologic characteristics of long-term autogenous vein grafts: A dynamic evolution. J Vasc Surg 1993;17:207-217.
21. Moody AP, Edwards PR, Harris PL. In situ versus reversed femoropopliteal vein grafts: Long-term follow-up of a prospective, randomized trial. Br J Surg 1992;79:750-752.
22. Licalzi LK, Stansel HC. Failure of autogenous reversed saphenous vein femoropopliteal grafting: Pathophysiology and prevention. Surgery 1982;91:352-358.
23. Logerfo FW, Corson JD, Mannick JA. Improved results with femoropopliteal vein grafts for limb salvage. Arch Surg 1977; 112:567-570.
24. Sonnenfeld T, Cronenstrand R. Factors determining outcome of reversed saphenous vein femoropopliteal bypass graft. Br J Surg 1980;93:1-4.
25. Wengerter KR, Veith FJ, Gupta SK, et al. Influence of vein size (diameter) on infrapopliteal reversed vein graft patency. J Vasc Surg 1990;11:525-531.
26. Watelet J, Peillon C. Pontages veineux fémoropoplités avec veine saphène inversée. Encyclopédie Médico-Chirurgicale (Paris-France), Techniques chirurgicales: Chirurgie vasculaire, 43029 F, 1991, 20 p.
27. Buchbinder D, Singh JK, Karmody AM, et al. Comparison of patency rate and structural changes of "in situ" and reversed vein arterial bypass. J Surg Res 1981;30:213-222.
28. Veterans Administration Cooperative Study Group 141 - Comparative evaluation of prosthetic, reversed, and in situ vein bypass grafts in distal popliteal and tibial-peroneal revascularization. Arch Surg 1988;123:434-438.